Publication | Closed Access

Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy

Concurrent ChemoradiotherapyCancer ImmunosurveillancePd-l1 ExpressionCd8+ Til DensityMedicinePathologyBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentLung CancerOncologyRadiation OncologyTumor Microenvironment